August 20, 2021
2:00 pm - 4:00 pm
CAD $300 + HST
Health Canada’s Cannabis Regulations mandates that licensed holders must not sell or export a cannabis product unless testing requirements are met for each lot or batch. Before cannabis product can be made available for sale, the Quality Assurance Person (QAP) must approve test results by signing off the Certificate of Analysis (C of A).
As the C of A is a technical document in nature, QA without laboratory experience can find it difficult to fully understand. It is vital for QA to understand and interpret test results on the C of A from third-party laboratories before signing off. The task may seem elementary to compare lab results to the specifications, but the C of A provides much more information than that. Understanding the results from the C of A can even help with improving production practices.
As well, during an audit, QA must be able to justify which methods were used for testing and why? What the specifications should be if the product is used for inhalation vs. ingestion? What tests are required for dried cannabis vs. extracts?
Understanding the C of A is crucial for product release. Improper approvals can lead to adverse effects, complaints, recalls, or regulatory action. In this webinar, we will explore Health Canada’s expectations on testing requirements, recommended methods, and specifications. As well, we will discuss handling of out-of-specification (OOS) results, reporting requirements and more.
At the end of the webinar, learners will:
Note: Course outline is subject to change without notice. Please check back regularly for updates.
This course is valuable for any individual with interested in Cannabis Regulatory Affairs, Quality Assurance, Quality Control, and anyone responsible for product release.